Topic |
Guidance/Reference |
Doc |
HRPP Policy
Ch(s) |
Acronyms |
|
|
|
Children in
Research |
|
GUI-9 |
5, 8, 9, 12, 14 |
Children in
Research |
|
GUI-1 |
5, 8, 9, 12, 14 |
Children in
Research |
|
OHRP |
5, 8, 9, 12, 14
|
Children in
Research |
|
GUI-C24 |
5, 8, 9, 12, 14
|
Children in
Research |
|
GUI-C34 |
5, 8, 9, 12, 14 |
Compassionate
Use |
|
GUI-36m |
5 |
Compassionate
Use |
|
GUI-19m |
5 |
| Confidentiality |
|
OHRP |
6, 11 |
| Confidentiality |
|
RPH |
6 |
| Confidentiality |
|
HRPP 11 |
11 |
| Conflict of Interest (COI) |
|
RPH |
2, 3,12 |
| Conflict of Interest (COI) |
|
DoR |
2, 3,12 |
| Conflict of Interest (COI) |
|
GUI-15 |
6 |
| Conflict of Interest (COI) |
|
RPT-I1 |
6 |
Consent |
|
GUI-C27 |
12 |
| Consent |
- General Requirements for Informed Consent:
Medical
|
GUI-C41 |
12 |
| Consent |
|
GUI-C41n |
12 |
| Consent |
|
IRB web |
12 |
| Consent |
|
PRO-C2 |
12 |
| Consent |
|
CHK-C15 |
12 |
| Consent |
|
GUI-C34 |
12 |
| Consent |
|
GUI-C2 |
12 |
| Consent |
|
GUI-32 |
12 |
| Consent |
|
IRB web |
12 |
Data & Safety Monitoring |
|
GUI-P20 |
3, 9, 11, 15 |
|
|
ISO web |
3, 9, 11, 15 |
| Data Security |
|
RPH |
3, 9, 11, 15 |
Devices |
|
FDA |
5 |
| Devices |
|
FDA |
5 |
| Devices |
|
GUI-7m |
5 |
| Devices |
|
FDA |
5 |
| Devices |
|
GUI-26m |
5 |
| Devices |
|
GUI-5m |
5 |
| Devices |
|
GUI-41m |
5 |
| Drugs |
|
RPH |
5 |
| Drugs |
|
FDA |
5 |
| Drugs |
|
GUI-35m |
5 |
Drugs |
|
GUI-26m |
5 |
| Drugs |
|
GUI-3m |
5 |
| Emergency Use of a Test Article |
|
GUI-6 |
5.8 |
| Emergency Use of a Test Article |
|
IRB web |
5.8 |
| Expanded Access to
Investigational Drugs and Devices |
|
GUI-19m |
5.8 |
Federal Agency Requirements
[DoD, DON, DOE, etc.] |
|
GUI-42 |
|
HIPAA |
|
GUI-3 |
4, 11 |
| HIPAA |
|
IRB web |
4, 11 |
| Human Subject Research |
|
APP-H8 |
1, 3 |
Human Subject Research |
|
FLW-H4 |
1, 3 |
| Human Subject Research |
|
GUI-H12 |
1, 3 |
| Humanitarian Use |
|
GUI-36m |
|
IRB Review |
- Criteria for IRB Approval of Research: Medical
|
GUI-40 |
7 |
| IRB Review |
|
GUI-40n |
7 |
| IRB Review |
|
GUI-4(p2) |
7 |
| IRB Review |
|
GUI-4(p1) |
7 |
| IRB Review |
|
GUI-12 |
7 |
| IRB Review |
|
GUI-15 |
7 |
| IRB Review |
|
AID-18 |
7 |
| IRB Review |
|
RPT-I1 |
7 |
| IRB Rosters & Authority |
|
CHG-1 |
1, 6 |
| IRB Rosters & Authority |
|
CHG-2 |
1, 6 |
| IRB Rosters & Authority |
|
RPH |
1, 6 |
| IRB Rosters & Authority |
|
IRB web |
1, 6 |
| International Research |
|
OHRP |
1 |
| MTA |
|
Stanford OTL |
|
| Multi-Site Research |
|
GUI-31 |
13 |
Payment |
|
GUI-39 |
10, 12, 14
|
| Payment |
|
AID-9 |
10, 12, 14 |
Prisoners |
|
GUI-38 |
9, 12 |
| Prisoners |
|
GUI-10 |
9, 12 |
| Radiation |
|
GUI- |
|
Radiation |
|
GUI- |
|
| Recruitment |
|
GUI-16 |
10, 20 |
Recruitment |
|
GUI-33 |
10, 20 |
| Recruitment |
|
RPH |
10, 20 |
| Recruitment |
|
GUI-15 |
10, 20 |
Reporting |
|
GUI-P13 |
3 |
| Risk |
|
GUI-14n |
9 |
| Security |
|
Stanford ISO web |
4, 11 |
Security |
|
GUI-35m |
4, 11 |
Short Form
Consent |
|
GUI-C39 |
12 |
Short Form
Consent |
|
IRB web |
12 |
Sponsor-
Investigator
Research
(SIR) |
|
AID-23m |
5, 15 |
Sponsor-
Investigator
Research
(SIR) |
|
GUI-5m |
5, 15 |
Sponsor-
Investigator
Research
(SIR) |
|
GUI-3m |
5, 15 |
Sponsor-
Investigator
Research
(SIR) |
|
GUI-41m |
5, 15 |
| Students |
|
GUI-14n |
9, 15 |
Students |
|
RPH |
9, 15 |
| Study Design |
|
GUI-17 |
1 |
| Terminology - clinical trials |
|
|
|
| Tissue & Samples |
|
|
11, 12, 13 |
| Tissue & Samples |
|
GUI-2m |
11, 12, 13 |
| Training |
|
RPH |
4 |
Waivers |
|
GUI-C2 |
12 |
| Women |
|
GUI-8 |
9, 12 |
Women |
|
RPH |
9, 12 |